Cardiol Therapeutics: HC Wainwright Raises Buy Rating to $9 from $8.

Tuesday, Feb 10, 2026 1:03 pm ET1min read
CRDL--

Cardiol Therapeutics: HC Wainwright Raises Buy Rating to $9 from $8.

Cardiol Therapeutics: HC Wainwright Raises Buy Rating to $9 from $8.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet